Company Profile
Akari Therapeutics, Plc
05252842•Public Limited With Share Capital
Get Full Access
07/10/2004
21 years
8
10
82990
high risk
Company Overview
Registration, classification & business activity
Akari Therapeutics, Plc (05252842) is a public limited with share capital incorporated on 07/10/2004 (21 years old) and registered in west sussex, BN993HH. The company operates under SIC code 82990 - other business support service activities n.e.c..
Akari therapeutics, plc (nasdaq: aktx) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement c5 activation and leukotriene b4 (ltb4) activity. akari’s pipel...
Financial Overview
£38.32M
£21.12M
£17.20M
£1.94M
Key Metrics
10
Employees
8
Directors
1
Shareholders
Board of Directors
Charges
2
Registered
0
Outstanding
0
Part Satisfied
2
Satisfied
Import / Export
Risk Assessment
high risk
International Score
Future Factor
emerging
Performance Rating